National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Genetics of Colorectal Cancer (PDQ®)
Health Professional Version   Last Modified: 12/19/2008
Table 3. Absolute Risks of Colorectal Cancer for Mutation Carriers in Hereditary Colorectal Cancer Syndromes

Syndrome  Absolute Risk in Mutation Carriers 
FAP 90% by age 45 y [1]
Attenuated FAP 69% by age 80 y [2]
Lynch 80% by age 75 ya [3]
MYH-associated neoplasia Not established
Peutz-Jeghers 39% by age 70 y [4]
Juvenile polyposis 17% to 68% by age 60 y [5,6]

FAP = familial adenomatous polyposis.
aSee text on Lynch syndrome for a full discussion of risk.

References

  1. Bussey HJ: Familial Polyposis Coli: Family Studies, Histopathology, Differential Diagnosis, and Results of Treatment. Baltimore, Md: The Johns Hopkins University Press, 1975. 

  2. Burt RW, Leppert MF, Slattery ML, et al.: Genetic testing and phenotype in a large kindred with attenuated familial adenomatous polyposis. Gastroenterology 127 (2): 444-51, 2004.  [PUBMED Abstract]

  3. Vasen HF, Wijnen JT, Menko FH, et al.: Cancer risk in families with hereditary nonpolyposis colorectal cancer diagnosed by mutation analysis. Gastroenterology 110 (4): 1020-7, 1996.  [PUBMED Abstract]

  4. Hearle N, Schumacher V, Menko FH, et al.: Frequency and spectrum of cancers in the Peutz-Jeghers syndrome. Clin Cancer Res 12 (10): 3209-15, 2006.  [PUBMED Abstract]

  5. Coburn MC, Pricolo VE, DeLuca FG, et al.: Malignant potential in intestinal juvenile polyposis syndromes. Ann Surg Oncol 2 (5): 386-91, 1995.  [PUBMED Abstract]

  6. Desai DC, Neale KF, Talbot IC, et al.: Juvenile polyposis. Br J Surg 82 (1): 14-7, 1995.  [PUBMED Abstract]


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov